This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Pandemic response
COVID-19 is impacting communities around the world. PATH and our partners are responding.

Training Supply Recommendations for DMPA-SC Rollout

Subcutaneous DMPA (DMPA-SC) is a three-month injectable contraceptive that is easy to use and uniquely suited for self-injection. Demonstration and practice injections are a key part of training programs for both health workers and self-injecting clients. Based on lessons learned in five countries, this memo summarizes PATH’s recommendations regarding devices for injection demonstration and practice, injection practice models, and waste disposal.

This memo is included as part of PATH's training materials for facility- and community-based family planning providers.

For more information, please visit, sign up for our newsletter or email

Publication date: March 2020

Training supply recommendations for DMPA-SC rollout: Practice injections, procurement, and disposal for health worker and self-injection client training

93.8 KB PDF

View Resource